Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 75,595 | 82,082 | 63,297 | 56,373 | 88,950 |
| Receivables | 111,760 | 93,133 | 115,889 | 127,041 | 126,809 |
| Inventories | 67,745 | 75,650 | 71,368 | 79,736 | 71,529 |
| TOTAL | $277,291 | $271,702 | $269,749 | $285,775 | $305,628 |
| Non-Current Assets | |||||
| PPE Net | 21,783 | 24,516 | 24,702 | 22,913 | 22,071 |
| Intangibles | 214,170 | 244,040 | 261,166 | 287,097 | 345,580 |
| Other Non-Current Assets | 51,044 | 60,136 | 66,910 | 42,355 | 36,640 |
| TOTAL | $286,997 | $328,692 | $352,778 | $352,365 | $404,291 |
| Total Assets | $564,288 | $600,394 | $622,527 | $638,140 | $709,919 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 50,000 | 35,000 | 35,000 | N/A |
| Accounts payable and accrued liabilities | 36,405 | 23,429 | 27,253 | 28,805 | 25,242 |
| Accrued Expenses | 48,135 | 44,236 | 54,451 | 52,568 | 51,738 |
| TOTAL | $114,601 | $145,752 | $142,821 | $133,446 | $92,137 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 5,840 | 19,665 | 69,474 | 154,283 |
| Deferred Revenues | 25,097 | 21,308 | 20,246 | 17,073 | 15,157 |
| Other Non-Current Liabilities | 23,804 | 27,410 | 29,667 | 19,845 | 21,995 |
| TOTAL | $24,937 | $43,548 | $63,583 | $106,250 | $195,685 |
| Total Liabilities | $139,538 | $189,300 | $206,404 | $239,696 | $287,822 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,408 | 33,874 | 34,105 | 33,777 | 33,160 |
| Common Shares | 353,737 | 342,828 | 344,476 | 334,215 | 316,577 |
| Retained earnings | 84,486 | 71,309 | 87,922 | 102,261 | 129,115 |
| Other shareholders' equity | -13,473 | -3,043 | -16,275 | -38,032 | -23,595 |
| TOTAL | $424,750 | $411,094 | $416,123 | $398,444 | $422,097 |
| Total Liabilities And Equity | $564,288 | $600,394 | $622,527 | $638,140 | $709,919 |